Previous studies did not pay attention to the effect of AL365361.1 on immunotherapy efficacy in HCC, or the effect of hsa-miR-17-5p and its target NLRP3, on drug resistance. The gene discussed is NLRP3; the disease is hepatocellular carcinoma.